BIOSEEK PLC | ||
| WKN: 940111 ISIN: GB0009231639 Ticker-Symbol: N/A |
Branche PharmaAktienmarkt nicht mehr börsennotiert | ||
- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten
Sprache: | Leser | Medien | |
|---|---|---|---|---|
| 07.11. | DiscoveRx Corporation Acquires BioSeek | 51 | Business Wire | |
| DiscoveRx Adds Primary Cell Assays to its Portfolio of Drug Discovery
Solutions
DiscoveRx today announced the acquisition of BioSeek, a drug discovery... Mehr lesen zu: DiscoveRx Corporation Acquires BioSeek | ||||
| 04.10. | BioSeek Awarded New Five-Year Contract from EPA ToxCast' Program | 23 | PR Newswire | |
| SOUTH SAN FRANCISCO, Calif., Oct. 4, 2012 /PRNewswire/ -- BioSeek, LLC today announced that it has been awarded a significant new contract extending and expanding the company's collaboration with... Mehr lesen zu: BioSeek Awarded New Five-Year Contract from EPA ToxCast' Program | ||||
| 01.08. | Stemgent Completes Acquisition of Asterand's Human Tissue Business | 65 | Business Wire | |
| Purchase is step in building leading research tools business focused
on human cells
Stemgent, Inc. announced today that it has completed the acquisition... Mehr lesen zu: Stemgent Completes Acquisition of Asterand's Human Tissue Business | ||||
3 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten:
VerkaufenHaltenKaufen
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten |
|---|---|---|---|
| PFIZER | 22,10 | +1,14 % | dpa-AFX Überblick: ANALYSTEN-EINSTUFUNGEN vom 14.06.2013: LUFTHANSA, RWE, VOLKSWAGEN, BMW, DAIMLER, DIALOG SEMICONDUCTOR, ENEL, RHOEN-KLINIKUM, CONTINENTAL, FRAPORT, GOOGLE, CTS EVENTIM, HEIDELBERGER ... |
| PHARMACYCLICS | 65,68 | +1,33 % | Research Abstracts, Phase 2 Results, and Market Availability of Formulations and Treatments- Research Report on Teva, Forest, Pharmacyclics, Cubist, and Dr. Reddy's |
| PAR PHARMACEUTICAL | 37,931 | -2,33 % | Par Pharmaceutical Begins Shipment of Generic Atacand |
| PHARMAXIS | 0,11 | +10 % | PHARMAXIS LTD: Pharmaxis Presents New Analyses of Pooled CF Data at EU Meet |
| STADA ARZNEIMITTEL | 33,85 | +0,30 % | DGAP-Stimmrechte: STADA Arzneimittel AG (deutsch) |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und mit der Push-Technologie von